Insight into the Progress in CAR-T Cell Therapy and Combination with Other Therapies for Glioblastoma

Glioblastoma (GBM) is the most common malignant primary brain cancer in adults. It is always resistant to existing treatments, including surgical resection, postoperative radiotherapy, and chemotherapy, which leads to a dismal prognosis and a high relapse rate. Therefore, novel curative therapies ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Tingyu, Song, Yixuan, Gu, Lingui, Wang, Yu, Ma, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503554/
https://www.ncbi.nlm.nih.gov/pubmed/37720174
http://dx.doi.org/10.2147/IJGM.S418837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503554/
https://www.ncbi.nlm.nih.gov/pubmed/37720174
http://dx.doi.org/10.2147/IJGM.S418837

Ejemplares similares